Some cancer survivors who have overcome the odds are facing another diagnosis: heart damage, from chemotherapy, radiation or immunotherapy. One Colorado doctors says they are developing cardiotoxicity ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

Testosterone treatment significantly reduces mortality among men with Klinefelter syndrome. Researcher calls for changes in guidelines to ensure more patients receive the necessary treatment.

CVRx , Inc. (NASDAQ:CVRX), a medical device company with a market capitalization of $382 million specializing in the development and commercialization of the Barostim therapy for heart failure and ...

The normal ejection fraction for the left ventricle is 55% to 60%. The general treatment for left-side heart failure is the same as for right-sided heart failure. However, different surgical ...

More than six million Americans are living with heart failure and over 900,000 new cases are being diagnosed each year. By the year 2030, the American Heart Association predicts nearly ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

Research Triangle Park, North Carolina Saturday, February 15, 2025, 17:00 Hrs [IST] ...

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...